Reducing Distress in Type 2 Diabetes: Spotlight-AQ CGM Pilot Study

  • Research type

    Research Study

  • Full title

    Spotlight-AQ & real-time CGM Pilot Study: Achieving Parity of Esteem

  • IRAS ID

    315237

  • Contact name

    Katharine Barnard-Kelly

  • Contact email

    katharinebarnard@bhrltd.com

  • Sponsor organisation

    BHR Ltd

  • Duration of Study in the UK

    0 years, 6 months, 29 days

  • Research summary

    The current study (subject to this ethics application) aims to focus investigation on whether Spotlight-AQ can improve onboarding processes for people using real-time continuous glucose monitoring systems (CGM). The reason being that it is known such devices can be burdensome as well as beneficial. If Spotlight-AQ can improved tailored onboarding, it could achieve parity of esteem between physical and mental health outcomes and reduce the burden.

    Aim: To determine the impact of specific tailored, patient-identified priority concerns on physical and mental health outcomes for adults with type 2 diabetes with sub-optimal glycaemic control.

    Population: Adults with type 2 diabetes
    Intervention: Spotlight-AQ in combination with real-time CGM
    Comparator: Usual Care
    Outcomes: Time in target glycaemic range; validated measure diabetes distress (DDS), glucose monitoring satisfaction (GMSS) and healthcare professional burnout (Maslach Burnout Inventory).
    Time: 3-month intervention

  • REC name

    London - Fulham Research Ethics Committee

  • REC reference

    22/PR/0578

  • Date of REC Opinion

    17 Jun 2022

  • REC opinion

    Further Information Favourable Opinion